2-[5-[[2-butyl-4-methyl-6-(7-methyl-1,3-benzoxazol-2-yl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid
C36H32N4O3 — CID 155531970
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-[[2-butyl-4-methyl-6-(7-methyl-1,3-benzoxazol-2-yl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid
2-[5-[[2-butyl-4-methyl-6-(7-methyl-1,3-benzoxazol-2-yl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid (PubChem CID 155531970) has the molecular formula C36H32N4O3 and a molecular weight of 568.68 g/mol. Its IUPAC name is 2-[5-[[2-butyl-4-methyl-6-(7-methyl-1,3-benzoxazol-2-yl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid.
Molecular Properties
| Compound Name | 2-[5-[[2-butyl-4-methyl-6-(7-methyl-1,3-benzoxazol-2-yl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid |
|---|---|
| PubChem CID | 155531970 |
| Molecular Formula | C36H32N4O3 |
| Molecular Weight | 568.68 g/mol |
| Exact Mass | 568.25 |
| IUPAC Name | 2-[5-[[2-butyl-4-methyl-6-(7-methyl-1,3-benzoxazol-2-yl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid |
| SMILES | CCCCc1nc2c(C)cc(-c3nc4cccc(C)c4o3)cc2n1Cc1ccc2c(ccn2-c2ccccc2C(=O)O)c1 |
| InChI | InChI=1S/C36H32N4O3/c1-4-5-13-32-38-33-23(3)18-26(35-37-28-11-8-9-22(2)34(28)43-35)20-31(33)40(32)21-24-14-15-29-25(19-24)16-17-39(29)30-12-7-6-10-27(30)36(41)42/h6-12,14-20H,4-5,13,21H2,1-3H3,(H,41,42) |
| InChIKey | FBIXKSJCISFVPW-UHFFFAOYSA-N |
| XLogP | 8.49 |
| TPSA | 86.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 568.68 |
| LogP ≤ 5 | 8.49 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155531970 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.